142 related articles for article (PubMed ID: 3148514)
21. Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.
Basaran M; Bavbek ES; Sakar B; Eralp Y; Alici S; Tas F; Yaman F; Dogan O O; Camlica H; Onat H
Am J Clin Oncol; 2001 Dec; 24(6):570-5. PubMed ID: 11801756
[TBL] [Abstract][Full Text] [Related]
22. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
[No Abstract] [Full Text] [Related]
23. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
24. Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Avilés A; Nambo MJ; Talavera A; Garcia EL; Huerta-Guzman J; Díaz Maqueo JC
Anticancer Drugs; 1997 Nov; 8(10):937-42. PubMed ID: 9436636
[TBL] [Abstract][Full Text] [Related]
25. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
[No Abstract] [Full Text] [Related]
26. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
27. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
[No Abstract] [Full Text] [Related]
28. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
[No Abstract] [Full Text] [Related]
29. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Machida U; Kami M; Hirai H
N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
[No Abstract] [Full Text] [Related]
30. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
Michiels JJ
Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
[No Abstract] [Full Text] [Related]
31. CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group.
Economopoulos T; Psyrri A; Dimopoulos MA; Kalogera-Fountzila A; Pavlidis N; Tsatalas C; Nikolaides C; Mellou S; Xiros N; Fountzilas G
Cancer J; 2007; 13(5):327-34. PubMed ID: 17921732
[TBL] [Abstract][Full Text] [Related]
32. [Epirubicin containing regimens in advanced malignant tumors report of 516 cases. Epirubicin Collaborative Study Group].
Zhonghua Nei Ke Za Zhi; 1997 Mar; 36(3):183-6. PubMed ID: 10374313
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
34. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
35. [2 patients with a non-Hodgkin lymphoma located in the pancreas].
de Jong RS; Damen RM; Westerveld BD; Nelis GF
Ned Tijdschr Geneeskd; 1992 Feb; 136(9):432-4. PubMed ID: 1542369
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
[No Abstract] [Full Text] [Related]
37. [C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)].
Ino T; Okamoto M; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Takada T; Morikawa K
Rinsho Ketsueki; 1987 Jun; 28(6):839-44. PubMed ID: 3669323
[No Abstract] [Full Text] [Related]
38. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
39. [Principles of treatment and military medical examination of the patients with indolent Non-Hodgkin's lymphomas].
Seriakov AP; Ushakov II; Ardashev VN; Mazurov VI; Korotkiĭ AN
Voen Med Zh; 2003 Oct; 324(10):34-41, 96. PubMed ID: 14671893
[TBL] [Abstract][Full Text] [Related]
40. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
Navarro JT; Ribera JM; Gómez-Espuch J; Feliu E
Med Clin (Barc); 1996 Jun; 107(3):118-9. PubMed ID: 8754503
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
